Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial | Zendy

Ruben A. Mesa | Zendy; Jason Gotlib | Zendy; Vikas Gupta | Zendy; John Catalano | Zendy; Michael W. Deininger | Zendy; Alan L. Shields | Zendy; Carole B. Miller | Zendy; Richard T. Silver | Zendy; Moshe Talpaz | Zendy; Elliott F. Winton | Zendy; Jimmie H. Harvey | Zendy; Thomas Hare | Zendy; Susan EricksonViitanen | Zendy; William Sun | Zendy; Victor Sandor | Zendy; Richard S. Levy | Zendy; Hagop M. Kantarjian | Zendy; Srđan Verstovšek | Zendy

Open Access

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

Author(s) -

Ruben A. Mesa,

Jason Gotlib,

Vikas Gupta,

John Catalano,

Michael W. Deininger,

Alan L. Shields,

Carole B. Miller,

Richard T. Silver,

Moshe Talpaz,

Elliott F. Winton,

Jimmie H. Harvey,

Thomas Hare,

Susan EricksonViitanen,

William Sun,

Victor Sandor,

Richard S. Levy,

Hagop M. Kantarjian,

Srđan Verstovšek

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.44.4489

Subject(s) - ruxolitinib , medicine , myelofibrosis , placebo , quality of life (healthcare) , physical therapy , clinical trial , randomized controlled trial , bone marrow , alternative medicine , pathology , nursing

To assess the effects of ruxolitinib on symptom burden and quality of life (QoL) and to evaluate the ability of the modified Myelofibrosis Symptom Assessment Form (MFSAF) v2.0 to measure meaningful changes in myelofibrosis-related symptoms in patients with myelofibrosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research